Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al
00:05:34 Vickie Danaher It also acts as an absorption enhancer, protecting the medication from degradation and boosting absorption
Some of these contraindications are due to known serious risks, and others are out of an abundance of caution based on early or inconclusive studies
In the SURMOUNT-1 study, adults without diabetes receiving tirzepatide 15 mg experienced an average weight reduction of 20.9% after 72 weeks
GLP-1 receptor agonists have been associated with increased risk of gallbladder disease (cholelithiasis, cholecystitis) and may worsen symptoms in patients with gastroparesis due to delayed gastric emptying
4, 2025 from MedlinePlus